News | Structural Heart | March 14, 2023

New Online Tool to Help Clinicians Calculate Patient Risk Associated with Mitral Valve Repair Surgery

The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the risk of mitral valve repair for patients with mitral valve prolapse and degenerative primary mitral regurgitation, or primary MR.

Getty Images


March 14, 2023 —  The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the risk of mitral valve repair for patients with mitral valve prolapse and degenerative primary mitral regurgitation, or primary MR. 

STS’s Risk Calculator for Surgical Repair of Primary Mitral Regurgitation enables providers to enter a patient’s demographics, risk factors such as smoking and diabetes, lab results, and details about their heart disease and surgical history. The Calculator then produces a result that provides statistically robust objective estimates of the patient’s individual risk for death or surgical complications. 

“Risk estimation for surgical intervention is an essential component of a heart team’s shared decision-making process,” said STS President Thomas MacGillivray, MD. “This important new STS Risk Calculator will make a significant difference for patients with mitral valve prolapse and regurgitation as it will give their cardiologists and surgeons an objective method to help determine the optimal course of treatment tailored to the individual.” 

The STS National Database accounts for over 97% of all heart operations performed in the United States. The new calculator utilizes contemporary and procedure-specific data from the STS Adult Cardiac Surgery Database that are most representative of the surgeries being performed today. 

“Recently published studies demonstrated that in the vast majority of patients with primary MR due to mitral valve prolapse, the risk of mortality associated with mitral valve repair surgery is less than 1%. These new data, specific for these patients, has informed the new STS risk calculator,” Dr. MacGillivray said. 

STS is a global leader in risk model development as a means to improve quality and patient care. Risk calculators, such as this new tool for primary MR, help inform multidisciplinary medical providers as they choose the optimal care for their patients. 

The STS National Database is one of largest clinical registries in healthcare, including more than 8 million records and over 97% of cardiothoracic operations performed in the United States. 

More detailed information about the Risk Calculator for Surgical Repair of Primary Mitral Regurgitation is available in The Annals of Thoracic Surgery: https://www.annalsthoracicsurgery.org/article/S0003-4975(22)01611-3/fulltext 

Click here to access the Calculator: Risk Calculator for Surgical Repair of Primary Mitral Regurgitation | STS 


Related Content

News | Structural Heart

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...

Home April 09, 2024
Home
News | Structural Heart

March 25, 2024 — In a groundbreaking medical advancement, three esteemed cardiologists from CLS Health, Dr. Bahaeddin ...

Home March 25, 2024
Home
News | Structural Heart

March 12, 2024 — Medtronic plc, a global leader in healthcare technology, today announced two late-breaking data ...

Home March 12, 2024
Home
News | Structural Heart

February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...

Home February 20, 2024
Home
News | Structural Heart

February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...

Home February 15, 2024
Home
News | Structural Heart

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

Home February 09, 2024
Home
News | Structural Heart

January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...

Home January 04, 2024
Home
News | Structural Heart

December 12, 2023 — Think of them as the Energizer Bunnies of the heart, tiny natural batteries that keep this vital ...

Home December 12, 2023
Home
News | Structural Heart

October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized ...

Home October 31, 2023
Home
News | Structural Heart

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

Home October 26, 2023
Home
Subscribe Now